123 related articles for article (PubMed ID: 10027661)
21. [Determination of lornoxicam in human plasma by LC/MS/MS].
Zeng YL; Chen XY; Zhang YF; Zhong DF
Yao Xue Xue Bao; 2004 Feb; 39(2):132-5. PubMed ID: 15127622
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.
Spahn H; Kirch W; Mutschler E; Ohnhaus EE; Kitteringham NR; Lögering HJ; Paar D
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):97S-102S. PubMed ID: 6743480
[TBL] [Abstract][Full Text] [Related]
23. Cinacalcet does not affect the pharmacokinetics or pharmacodynamics of warfarin.
Padhi D; Sullivan JT
Drugs R D; 2007; 8(2):79-87. PubMed ID: 17324005
[TBL] [Abstract][Full Text] [Related]
24. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro.
Berg J; Fellier H; Christoph T; Grarup J; Stimmeder D
Inflamm Res; 1999 Jul; 48(7):369-79. PubMed ID: 10450786
[TBL] [Abstract][Full Text] [Related]
25. The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers.
Yates RA; Wong J; Seiberling M; Merz M; März W; Nauck M
Br J Clin Pharmacol; 2001 May; 51(5):429-35. PubMed ID: 11422000
[TBL] [Abstract][Full Text] [Related]
26. Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype.
Zhang Y; Zhong D; Si D; Guo Y; Chen X; Zhou H
Br J Clin Pharmacol; 2005 Jan; 59(1):14-7. PubMed ID: 15606435
[TBL] [Abstract][Full Text] [Related]
27. Absence of interaction between ramipril, a new ACE-inhibitor, and phenprocoumon, an anticoagulant agent.
Verho M; Malerczyk V; Grötsch H; Zenbil I
Pharmatherapeutica; 1989; 5(6):392-9. PubMed ID: 2531901
[TBL] [Abstract][Full Text] [Related]
28. A pharmacokinetic interaction between cimetidine or ranitidine and lornoxicam.
Ravic M; Salas-Herrera I; Johnston A; Turner P; Foley K; Rosenow DE
Postgrad Med J; 1993 Nov; 69(817):865-6. PubMed ID: 8290432
[TBL] [Abstract][Full Text] [Related]
29. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers.
Rahimy M; Hallén B; Narang P
Arzneimittelforschung; 2002; 52(12):890-5. PubMed ID: 12572529
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
Beinema M; Brouwers JR; Schalekamp T; Wilffert B
Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
Olkkola KT; Brunetto AV; Mattila MJ
Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
[TBL] [Abstract][Full Text] [Related]
32. Effects of intravenous ibuprofen and lornoxicam on erythrocyte deformability in rats undergoing hind limb ischemia reperfusion injury.
Sivgin V; Kucuk A; Comu FM; Kosem B; Kartal S; Turgut HC; Arpaci H; Aydin ME; Koc DS; Ozer A; Arslan M; Alkan M
Bratisl Lek Listy; 2016; 117(12):722-725. PubMed ID: 28127969
[TBL] [Abstract][Full Text] [Related]
33. Effect of intraarticular injection of lornoxicam on the articular cartilage & synovium in rat.
Saricaoglu F; Dal D; Atilla P; Iskit AB; Tarhan O; Aşan E; Aypar UA
Indian J Med Res; 2008 Apr; 127(4):362-5. PubMed ID: 18577790
[TBL] [Abstract][Full Text] [Related]
34. The effect of repeated oral doses of lornoxicam on antipyrine elimination in normal human volunteers.
Ravic M; Johnston A; Turner P; Takacs F; Rosenow DE
Hum Exp Toxicol; 1991 Sep; 10(5):375-7. PubMed ID: 1683552
[TBL] [Abstract][Full Text] [Related]
35. Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature.
Thorsen S; Teisner A; Jensen SA; Philips M; Dalhoff K; Bendtsen F
Scand J Clin Lab Invest; 2009; 69(6):643-50. PubMed ID: 19530032
[TBL] [Abstract][Full Text] [Related]
36. The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAID.
Dittrich P; Radhofer-Welte S; Magometschnigg D; Kukovetz WR; Mayerhofer S; Ferber HP
Drugs Exp Clin Res; 1990; 16(2):57-62. PubMed ID: 2401187
[TBL] [Abstract][Full Text] [Related]
37. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
[TBL] [Abstract][Full Text] [Related]
38. Effect of the CYP2C9*3 allele on lornoxicam metabolism.
Liu YL; Zhang W; Tan ZR; Ouyang DS; Luo CH; Liu ZQ; Qiu Y; Chen Y; He YJ; Zhou G; Zhou HH
Clin Chim Acta; 2006 Feb; 364(1-2):287-91. PubMed ID: 16182270
[TBL] [Abstract][Full Text] [Related]
39. Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats.
Schmidt W; Jähnchen E
J Pharmacokinet Biopharm; 1979 Dec; 7(6):643-63. PubMed ID: 529027
[TBL] [Abstract][Full Text] [Related]
40. Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tablets.
Bareggi SR; Gambaro V; Valenti M; Benvenuti C
Arzneimittelforschung; 1997 Jun; 47(6):755-7. PubMed ID: 9239455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
